EXICURE, INC. Uncategorized Contracts & Agreements
12 Contracts & Agreements
- Amended and Restated Employment Agreement (Filed With SEC on June 1, 2023)
- Separation and Release Agreement (Filed With SEC on June 1, 2023)
- Letter Agreement, dated December 13, 2022, by and between Exicure, Inc. and Allergan Pharmaceuticals International Limited (Filed With SEC on December 14, 2022)
- Advisor Agreement by and between Exicure, Inc. and Brian C. Bock (Filed With SEC on February 4, 2022)
- Side Agreement to Northwestern Agreements by and among Exicure Inc., Northwestern University and Ipsen Biopharm Limited dated as of July 30, 2021 (Filed With SEC on November 19, 2021)
- Inducement Award Agreement between the Company and Brian Bock, dated May 13, 2021 (Filed With SEC on May 13, 2021)
- Amendment No. 1 (Filed With SEC on November 12, 2020)
- Side Agreement to Northwestern Agreements by and among Exicure Inc., Northwestern University and Allergan Pharmaceuticals International Limited dated as of November 13, 2019 (Filed With SEC on March 10, 2020)
- Description of Securities (Filed With SEC on March 10, 2020)
- Offer Letter dated as of January 18, 2018 by and between Exicure, Inc. and Matthias G. Schroff, Ph.D (Filed With SEC on May 15, 2018)
- Form of Pre-Merger Indemnity Agreement (Filed With SEC on October 2, 2017)
- First Amendment to Offer Letter dated as of January 8, 2016 by and between Exicure OpCo and Ekambar Kandimalla, Ph.D (Filed With SEC on October 2, 2017)
